QSIAW
Quantum-Si incorporatedKey Statistics
About Quantum-Si incorporated
Quantum-Si Incorporated is a pioneering life sciences technology company dedicated to revolutionizing protein sequencing through its proprietary single-molecule technology and advanced quantum dot capabilities. By delivering high-throughput and cost-effective sequencing solutions, Quantum-Si aims to transform protein analysis and accelerate advancements in genomics and personalized medicine. Supported by a robust intellectual property portfolio, the company is strategically positioned to capitalize on the growing demand for innovative sequencing technologies, thus driving substantial progress in life sciences research and clinical applications.
Fundamentals
| Revenue (TTM) | $1.85M |
| Gross Profit (TTM) | 741,000 |
| EBITDA | $-91.23M |
| Operating Margin | -9323.00% |
| Return on Equity | -46.40% |
| Return on Assets | -24.80% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.92 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -69.40% |
| Shares Outstanding | 0 |
| Float | $179.33M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on QSIAW and any ticker you trade — then tracks every position and per-strategy win rate.